Exclusives

MediWound announced it has entered into a $25.0MM definitive share purchase agreement with several new and existing investors, including $15.0MM from Mölnlycke Health Care. The proceeds will fund advancing EscharEx pre-commercial activities...

CMS released the Q224 Drug and Biologicals Final Quarterly Coding Decisions and added 12 new Q codes, including multiple new codes for Tides Medical's Artacent products, another new code for Merakris Therapeutics' Dermacyte and some newer...

A 149-patient study evaluated the use and performance of Biatain Fiber dressing in the management of wounds in community nursing practice. The study found patients who received treatment with the gelling fibers experienced improvements in the...

IART announced plans to restart the manufacture of PriMatrix and SurgiMend at its new manufacturing facility in Braintree, MA. The new facility should be operational in H126 and will provide the flexibility to implement more effective quality...

Gel4Med announced that its G4Derm Product Line was recognized in Podiatry Today as one of the Top 10 Innovations in Podiatry. The advanced polypeptide matrix comes in a flowable form factor and forms a scaffold that facilitates wound healing...

The Federal Association of Specialized Service Providers "Wound" (BAG-Wunde) was founded. It consists of participants from outpatient nursing services, local home care facilities and specialists to define principles and structures to build...

BioStem announced that the Institute Review Board (IRB) approved a clinical study to evaluate the efficacy of AmnioWrap2 (AW2) in patients with DFU. Once BioStem completes the study, the company plans to commercially advance AW2 with expanded...

A 250-patient study will investigate the efficacy and safety of allo-APZ2-CVU administered topically for treatment of non-healing venous ulcers with the primary outcome of complete wound closure at 18 weeks. Not yet recruiting; estimated...